Cargando…

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients

The SARS-CoV-2 infection has spread rapidly around the world causing millions of deaths. Several treatments can reduce mortality and hospitalization. However, their efficacy depends on the choice of the molecule and the precise timing of its administration to ensure viral clearance and avoid a delet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cremoni, Marion, Allouche, Jonathan, Graça, Daisy, Zorzi, Kevin, Fernandez, Céline, Teisseyre, Maxime, Benzaken, Sylvia, Ruetsch-Chelli, Caroline, Esnault, Vincent L. M., Dellamonica, Jean, Carles, Michel, Barrière, Jérôme, Ticchioni, Michel, Brglez, Vesna, Seitz-Polski, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548596/ https://www.ncbi.nlm.nih.gov/pubmed/36225915 http://dx.doi.org/10.3389/fimmu.2022.953502

Ejemplares similares

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France
por: Graça, Daisy, et al.
Publicado: (2023)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
por: Cremoni, Marion, et al.
Publicado: (2021)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
por: Gérard, Alexandre, et al.
Publicado: (2021)

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study
por: Allouche, Jonathan, et al.
Publicado: (2022)

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
por: Cremoni, Marion, et al.
Publicado: (2020)

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
por: Manni, Sabrina, et al.
Publicado: (2023)

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
por: Ruetsch, Caroline, et al.
Publicado: (2021)

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
por: Re, Daniel, et al.
Publicado: (2022)

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
por: Brglez, Vesna, et al.
Publicado: (2020)

Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care Intensity
por: Doyen, Denis, et al.
Publicado: (2022)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
por: Lebrun, Christine, et al.
Publicado: (2018)

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)

Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19
por: Occelli, Céline, et al.
Publicado: (2022)

Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
por: Lateb, Maël, et al.
Publicado: (2019)

The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review
por: Vassallo, Matteo, et al.
Publicado: (2012)

Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
por: Barrière, Jérôme, et al.
Publicado: (2022)

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities
por: Levraut, Michael, et al.
Publicado: (2022)

Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus
por: Wincup, Chris, et al.
Publicado: (2022)

Proteinuria as a Biomarker for COVID-19 Severity
por: Ouahmi, Hajar, et al.
Publicado: (2021)

Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023)

Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation
por: Vassallo, M., et al.
Publicado: (2020)

Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?
por: Vassallo, Matteo, et al.
Publicado: (2021)

Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients
por: Giunta, Emilio Francesco, et al.
Publicado: (2020)

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
por: Barrière, Jérôme, et al.
Publicado: (2021)

Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study
por: Bailly, Laurent, et al.
Publicado: (2022)

Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis
por: Ruetsch-Chelli, Caroline, et al.
Publicado: (2022)

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
por: Massa, Filippo, et al.
Publicado: (2021)

Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers
por: Barrière, Jérôme, et al.
Publicado: (2022)

Letter to Editor “Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs”: Important concerns on the validity of this article
por: Barrière, Jérôme, et al.
Publicado: (2023)

Idiopathic CD4 T Cell Lymphocytopenia: A Case of Overexpression of PD-1/PDL-1 and CTLA-4
por: Kumar, Gaurav, et al.
Publicado: (2021)

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)
por: Gougeon, Marie-Lise, et al.
Publicado: (2017)

Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)’
por: Gougeon, Marie-Lise, et al.
Publicado: (2017)

Préconisations pour protéger les patients de la filière oncologique face au variant Omicron
por: Barrière, Jérôme, et al.
Publicado: (2022)

Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells
por: Barrière, Guislaine, et al.
Publicado: (2012)

Late ventilator-associated pneumonia: analysis of baseline characteristics and clinical outcomes in the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qvtfj07ff4h1m3e7brebiai88g